SpringWorks Therapeutics News

SWTXDelisted Stock  USD 46.99  0.00  0.00%   
Slightly above 56% of SpringWorks Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading SpringWorks Therapeutics stock suggests that many investors are alarmed at this time. SpringWorks Therapeutics' investing sentiment can be driven by a variety of factors including economic data, SpringWorks Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
over three months ago at thelincolnianonline.com         
Promising Growth Stocks Worth Watching April 28th
news
over three months ago at thelincolnianonline.com         
SpringWorks Therapeutics Projected to Post Quarterly Earnings on Thursday
news
over three months ago at gurufocus.com         
SpringWorks Therapeutics Downgraded Amid Acquisition Deal SWTX Stock News
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
SpringWorks Therapeutics Downgraded After Acquisition Agreement SWTX Stock News
Gurufocus Stories at Macroaxis
over three months ago at thelincolnianonline.com         
SpringWorks Therapeutics, Inc. Receives Average Recommendation of Moderate Buy from Brokerages
news
over three months ago at bizjournals.com         
Public company in RTP acquired for nearly 4 billion
bizjournals News
over three months ago at medcitynews.com         
Merck KGaAs Rare Tumor Strategy Takes Shape With 3.9B SpringWorks Acquisition
news
over three months ago at businesswire.com         
Shareholder Alert The Ademi Firm Investigates Whether SpringWorks Therapeutics, Inc. Is Obtaining a ...
businesswire News
over three months ago at businesswire.com         
Shareholder Alert The Ademi Firm Investigates Whether SpringWorks Therapeutics, Inc. Is Obtaining a ...
businesswire News
over three months ago at aa.com.tr         
German pharma firm Merck to acquire US-based SpringWorks Therapeutics for 3.9B
news
over three months ago at gurufocus.com         
SpringWorks Therapeutics Downgraded Following Merck Acquisition Deal SWTX Stock News
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
SpringWorks Therapeutics Downgraded by Barclays Following Merck Acquisition SWTX Stock News
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
SpringWorks Therapeutics Downgraded by Wedbush Following Acquisition Announcement SWTX ...
Gurufocus Stories at Macroaxis
over three months ago at finance.yahoo.com         
Merck KGaA to buy biotech SpringWorks for 3.9B
Yahoo News
over three months ago at gurufocus.com         
SpringWorks Therapeutics Inc Under Investigation for Merger Fairness SWTX stock news
Gurufocus Stories at Macroaxis
There is far too much social signal, news, headlines, and media speculation about SpringWorks Therapeutics that are available to investors today. This information is accessible both publicly - through SpringWorks Therapeutics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of SpringWorks-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of SpringWorks Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of SpringWorks Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to SpringWorks Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive SpringWorks Therapeutics alpha.

SpringWorks Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
SpringWorks Therapeutics, Inc. Receives Average Recommendation of Moderate Buy from Brokerages
04/28/2025
2
SpringWorks Therapeutics Projected to Post Quarterly Earnings on Thursday
04/29/2025
3
SpringWorks Therapeutics, Inc. Shares Sold by D. E. Shaw Co. Inc.
05/14/2025
4
SpringWorks Therapeutics Surged on Acquisition News
05/27/2025
5
SpringWorks Therapeutics, Inc. Receives 52.57 Average Price Target from Brokerages
05/30/2025
6
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates LNSR, SWTX, ICAD, SSBK on Behalf of ...
06/04/2025
7
SpringWorks Therapeutics Sees Large Volume Increase - Still a Buy - MarketBeat
06/12/2025
8
Top Growth Stocks To Follow Today June 16th
06/17/2025
9
SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of ...
06/20/2025
10
Is Springworks Therapeutics, Inc. overvalued or undervalued - MarketsMojo
06/25/2025
11
Growth Stocks To Watch Today June 27th
06/30/2025
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in SpringWorks Stock

If you are still planning to invest in SpringWorks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SpringWorks Therapeutics' history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon